397 related articles for article (PubMed ID: 32630630)
21. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
Spillantini MG; Goedert M
Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
[TBL] [Abstract][Full Text] [Related]
22. Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease.
Smolders S; Philtjens S; Crosiers D; Sieben A; Hens E; Heeman B; Van Mossevelde S; Pals P; Asselbergh B; Dos Santos Dias R; Vermeiren Y; Vandenberghe R; Engelborghs S; De Deyn PP; Martin JJ; Cras P; Annaert W; Van Broeckhoven C;
Acta Neuropathol Commun; 2021 Feb; 9(1):25. PubMed ID: 33579389
[TBL] [Abstract][Full Text] [Related]
23. Phytochemicals as Regulators of Genes Involved in Synucleinopathies.
Surguchov A; Bernal L; Surguchev AA
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33922207
[TBL] [Abstract][Full Text] [Related]
24. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
Peelaerts W; Baekelandt V
J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
[TBL] [Abstract][Full Text] [Related]
25. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD.
Mori H
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S41-5. PubMed ID: 15885628
[TBL] [Abstract][Full Text] [Related]
26. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.
Jellinger KA
Mov Disord; 2012 Jan; 27(1):8-30. PubMed ID: 22081500
[TBL] [Abstract][Full Text] [Related]
27. Methylation changes and aberrant expression of FGFR3 in Lewy body disease neurons.
Tsuchida T; Mano T; Koshi-Mano K; Bannai T; Matsubara T; Yamashita S; Ushijima T; Nagata K; Murayama S; Toda T; Tsuji S; Iwata A
Brain Res; 2018 Oct; 1697():59-66. PubMed ID: 29909202
[TBL] [Abstract][Full Text] [Related]
28. [Cerebrospinal fluid and plasma biomarkers for dementia with lewy bodies].
Kasuga K; Ikeuchi T
Brain Nerve; 2012 May; 64(5):505-13. PubMed ID: 22570064
[TBL] [Abstract][Full Text] [Related]
29. Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases.
Kon T; Tomiyama M; Wakabayashi K
Neuropathology; 2020 Feb; 40(1):30-39. PubMed ID: 31498507
[TBL] [Abstract][Full Text] [Related]
30. PD and DLB: Brain imaging in Parkinson's disease and dementia with Lewy bodies.
Berman SB; Miller-Patterson C
Prog Mol Biol Transl Sci; 2019; 165():167-185. PubMed ID: 31481162
[TBL] [Abstract][Full Text] [Related]
31. The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease.
Hashimoto M; Kawahara K; Bar-On P; Rockenstein E; Crews L; Masliah E
J Mol Neurosci; 2004; 24(3):343-52. PubMed ID: 15655259
[TBL] [Abstract][Full Text] [Related]
32. [Autonomic Dysfunction and Skin Biopsy in Dementia with Lewy Bodies].
Orimo S
Brain Nerve; 2018 Aug; 70(8):915-927. PubMed ID: 30082501
[TBL] [Abstract][Full Text] [Related]
33. ɑ-Synuclein strains and seeding in Parkinson's disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences.
Peelaerts W; Bousset L; Baekelandt V; Melki R
Cell Tissue Res; 2018 Jul; 373(1):195-212. PubMed ID: 29704213
[TBL] [Abstract][Full Text] [Related]
34. Neuropathological spectrum of synucleinopathies.
Jellinger KA
Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
[TBL] [Abstract][Full Text] [Related]
35. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
36. Pathological roles of α-synuclein in neurological disorders.
Vekrellis K; Xilouri M; Emmanouilidou E; Rideout HJ; Stefanis L
Lancet Neurol; 2011 Nov; 10(11):1015-25. PubMed ID: 22014436
[TBL] [Abstract][Full Text] [Related]
37. A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease.
Smith BR; Nelson KM; Kemper LJ; Leinonen-Wright K; Petersen A; Keene CD; Ashe KH
Acta Neuropathol Commun; 2019 Jul; 7(1):124. PubMed ID: 31362787
[TBL] [Abstract][Full Text] [Related]
38. α-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration.
Beyer K; Ariza A
Mol Neurobiol; 2013 Apr; 47(2):509-24. PubMed ID: 22923347
[TBL] [Abstract][Full Text] [Related]
39. Pathological biochemistry of alpha-synucleinopathy.
Iwatsubo T
Neuropathology; 2007 Oct; 27(5):474-8. PubMed ID: 18018483
[TBL] [Abstract][Full Text] [Related]
40. Latest concept of Lewy body disease.
Kosaka K
Psychiatry Clin Neurosci; 2014 Jun; 68(6):391-4. PubMed ID: 24597591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
